Associate Professor Michael Pollastri spent a decade in the pharmaceutical industry before coming to Northeastern University to focus on finding cures for neglected tropical diseases. The NIH grant will help him continue his work in drug discovery for what’s commonly known as sleeping sickness.
Dana Klug, Chemistry PhD candidate, sits down with the College of Science Graduate Program staff to talk about what it’s like to work and study at Northeastern University.
The seventh row of the periodic table is now complete after Monday’s announcement of four new elements. Chemistry professor Michael Pollastri explains why this is an important milestone for science.
The neglected tropical disease affects thousands of people and is mostly fatal. Now, new research co-authored by Northeastern chemistry professor Michael Pollastri has identified hundreds of compounds that could lead to a cure.
During a keynote address at Northeastern on Tuesday, an epidemiologist at Boston Medical Center who has administered care to Ebola patients in Sierra Leone, noted that more help is needed in Africa to provide healthcare services, adding that “We need help with everything.”
A group of Northeastern students has joined the crusade to bring an end to the 17 neglected tropical diseases that affect more than 1 billion people around the world. Called NEU END7, the group has been working since October to raise awareness of NTDs and help eradicate the seven most common tropical infections by 2020.
In one of the largest science-research-based crowdfunding campaigns to date, Northeastern University College of Science associate professor Michael Pollastri raised $25,031.
Professor Michael Pollastri is creating a new platform to share data with international researchers focused on neglected tropical diseases.
The secrecy model that dominates drug discovery doesn’t work for neglected tropical diseases. Associate Professor Michael Pollastri hopes to shift that paradigm with a new platform for secure data-sharing.
Listen to chemistry professor Michael Pollastri talk about his work finding treatments for NTDs.